Switch to:
More From Other Websites
REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 02 2017
Repros Announces New CEO Feb 02 2017
FDA Grants End of Phase 2 Meeting to Discuss Phase 3 Requirements for Oral Proellex® in the... Jan 30 2017
Repros Requests Meeting With FDA to Discuss Phase 3 Requirements for Proellex® in the Treatment of... Dec 19 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 19 2016
Repros Requests Meeting With FDA to Discuss Phase 3 Requirements for Proellex® in the Treatment of... Dec 19 2016
Repros to Meet with the FDA for Phase III Proellex Program Dec 13 2016
How Bonanza Creek Energy Inc (BCEI) Stacks Up In Relation to Its Peers Dec 13 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 12 2016
Repros Requests Meeting With FDA to Discuss Phase 3 Requirements for Proellex® in the Treatment of... Dec 12 2016
7 Companies That Destroyed Shareholders Last Week Dec 10 2016
Repros Therapeutics Drops on FDA Vote Dec 07 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 07 2016
FDA Advisory Committee Discusses Clinical Trial Designs for Obesity-Related Hypogonadism Dec 06 2016
10 Major Pharma and FDA Catalysts Coming in December Dec 05 2016
REPROS THERAPEUTICS INC. Financials Nov 17 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Nov 15 2016
Repros (RPRX) Reports Positive Top-Line Data on Proellex Nov 15 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Nov 14 2016
Repros (RPRX) Loss Narrower Y/Y in Q3, Pipeline in Focus Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK